Indexed with PubMed and Science Citation Index (E) 
Users online: 12843 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
    Next article
    Previous article
    Table of Contents

    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


Year : 1993  |  Volume : 59  |  Issue : 2  |  Page : 71--73

Oral acyclovir in recurrent genital herpes

Correspondence Address:
R K Pandhi

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Recurrent genital herpes (RGH) is a difficult condition to treat. Oral acyclovir therapy has been shown to have a definite role in suppressing the recurrent episodes of the disease. Most studies, however, are available from the West. We report our experience with oral acyclovir therapy. Ten patients of RGH with more than 8 episodes/year received acylovir in the dose of 200 mg thrice daily for 6 months. They were followed up for a period ranging from 6 months to 3.5 years. Eight patients stayed symptom-free while on therapy and during the follow-up period. One patient showed a recurrence while on treatment and another 4 months after stopping treatment. No adverse effects were seen in any of the patients.

[FULL TEXT] [PDF Not available]*

Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow